The Gorilla Case in Slovakia
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
"Coping with Corruption Toolkit" Promoting Islands of Integrity
FINAL REPORT The Integra Foundation - "Coping with Corruption ToolKit" Promoting Islands of Integrity: Measuring and encouraging the ability of Slovak SME's to resist corruption and do ethical business Bratislava, August 3 1, 2000 Award number: 193-A-00-99-00104-00 (previous award number: 193-0020-G-00-9104-00) Prepared by: Monika Benfoddova Allan Bussard The Integra Foundation MiSikova 28/B 81 1 06 Bratislava SLOVAKIA phone: +421 (07) 52444246-7 fax: +42 1 (07) 52494 184 e-mail: [email protected] web: www.integra.sk Project Activities from October 1,1999 to May 31,2000 1. Key parameters determination Based on consultation with specialist In discussion with the local branch of Transparency International (TI) In discussion with David Murray of Transparency International UK. In discussion with representatives of the Association of MicroFinance Institutions of Slovakia. (AMIS) and on the basis of specialized studies related to the theme of corruption we determinated 24 key parameters which were tracked in the course of the project. These were anticipated to revolve around the common issues of bribery, kickbacks, extortion, nepotism, influence peddling, collusion, etc. 2. Client Survey creation On the basis of the parameters determined above we compiled a questionaire. The survey contains 43 questions which can be divided into the following parts: personal attitude to corruption practices 0 practice / reality that entrepreneurs meet potential solutions to these problems This survey was created in order to determine the primary environmental issues - legislative, judicial, economic, social - that impact ethical business behavior in Slovakia and find out some possible methods which Slovak SME's can use to avoid corruption practices. -
Media Influence Matrix Slovakia
J A N U A R Y 2 0 2 0 MEDIA INFLUENCE MATRIX: SLOVAKIA Government, Politics and Regulation Author: Marius Dragomir 2nd updated edition Published by CEU Center for Media, Data and Society (CMDS), Budapest, 2020 About CMDS About the author The Center for Media, Data and Society Marius Dragomir is the Director of the Center (CMDS) is a research center for the study of for Media, Data and Society. He previously media, communication, and information worked for the Open Society Foundations (OSF) policy and its impact on society and for over a decade. Since 2007, he has managed practice. Founded in 2004 as the Center for the research and policy portfolio of the Program Media and Communication Studies, CMDS on Independent Journalism (PIJ), formerly the is part of Central European University’s Network Media Program (NMP), in London. He School of Public Policy and serves as a focal has also been one of the main editors for PIJ's point for an international network of flagship research and advocacy project, Mapping acclaimed scholars, research institutions Digital Media, which covered 56 countries and activists. worldwide, and he was the main writer and editor of OSF’s Television Across Europe, a comparative study of broadcast policies in 20 European countries. CMDS ADVISORY BOARD Clara-Luz Álvarez Floriana Fossato Ellen Hume Monroe Price Anya Schiffrin Stefaan G. Verhulst Hungary, 1051 Budapest, Nador u. 9. Tel: +36 1 327 3000 / 2609 Fax: +36 1 235 6168 E-mail: [email protected] ABOUT THE MEDIA INFLUENCE MATRIX The Media Influence Matrix Project is run collaboratively by the Media & Power Research Consortium, which consists of local as well as regional and international organizations. -
Governance and Corruption in Public Health Care Systems by Maureen Lewis
Working Paper Number 78 January 2006 Governance and Corruption in Public Health Care Systems By Maureen Lewis Abstract What factors affect health care delivery in the developing world? Anecdotal evidence of lives cut tragically short and the loss of productivity due to avoidable diseases is an area of salient concern in global health and international development. This working paper looks at factual evidence to describe the main challenges facing health care delivery in developing countries, including absenteeism, corruption, informal payments, and mismanagement. The author concludes that good governance is important in ensuring effective health care delivery, and that returns to investments in health are low where governance issues are not addressed. The Center for Global Development is an independent think tank that works to reduce global poverty and inequality through rigorous research and active engagement with the policy community. This Working Paper was made possible in part by funding from the William and Flora Hewlett Foundation. Use and dissemination of this Working Paper is encouraged, however reproduced copies may not be used for commercial purposes. Further usage is permitted under the terms of the Creative Commons License. The views expressed in this paper are those of the author and should not be attributed to the directors or funders of the Center for Global Development. www.cgdev.org 1 Governance and Corruption in Public Health Care Systems Maureen Lewis* Senior Fellow Center for Global Development January 2006 * I am grateful to William Savedoff for extensive peer review comments and suggestions, and to James Habyarimana, John Hicklin, Randi Ryterman, Julian Schweitzer, Peter Heller and Adam Wagstaff for helpful comments on earlier drafts. -
Penta Holding Limited /Annual Report 2007
Penta Holding Limited / Annual Report 2007 It doesn´t take just seeding – it takes more to have a good harvest. We know how. With the right care a single seed can be grown into a strong plant and the whole fi eld can fl ourish from its fruitage. Contents 04 Tombstones 06 Financial Highlights 08 Our Profi le 10 Director’s Statement 14 Holding Structure 16 Partners 18 Operational Structure 20 Penta’s Key Investments 30 Management Discussion & Analysis 40 Penta Holding Limited 50 Penta Investments Limited 60 Contacts Completed Investments ADAST, a.s. Letisko Košice, a.s. Slovenské lodenice, a.s. manufacturing transport manufacturing Czech Republic Slovakia Slovakia Česká konsolidační agentura Reštitučný investičný fond, a.s. Slovnaft, a.s. fi nancial investment fund oil and gas Czech Republic Slovakia Slovakia Severomoravské vodovody Drôtovňa Hlohovec, a.s. a kanalizace Ostrava a.s. Tento, a.s. manufacturing utilities manufacturing Slovakia Czech Republic Slovakia Elektrovod Bratislava, a.s. Slovenská plavba a prístavy, a.s. VÚB Kupón utilities transport investment fund Slovakia Slovakia Slovakia Chemolak, a.s. Slovenská poisťovňa, a.s. manufacturing insurance Slovakia Slovakia Real Estate Projects Digital Park, a.s. The Port, a.s. real estate real estate Slovakia Slovakia Investments in Progress Mobile Entertainment Company, a.s./ AERO Vodochody a.s. MOBILKING VSŽ - slovenské investičné družstvo aerospace telecommunications metal industry Czech Republic Poland Slovakia Alpha Medical Ventures, s.r.o. MobilKom, a.s./U:fon ZSNP, a.s. health care telecommunications metal industry Slovakia Czech Republic Slovakia AVC, a.s. PM Zbrojníky, a.s. Žabka manufacturing food processing retail Slovakia Slovakia Poland, Czech Republic Dr. -
Pharma Drives Economic Growth in Central Europe
What the doctor ordered: Pharma drives economic growth in Central Europe Leveraging location, low costs, and strong legacy companies with a skilled labour pool, the pharmaceutical industry is a quiet success story in Central and Eastern Europe (CEE). The sector is a major contributor to exports and R&D spending in several countries, and has become a magnet for M&A deals in recent years. International pharmaceutical companies have a strong manufacturing presence across the CEE region, producing and exporting a wide range of products. US multinational Teva, for example, gained CEE assets – including two generics factories in Bulgaria and oncology drugs facility in Romania – when it acquired Allergan’s Actavis Generics in 2016. Meanwhile, Sanofi announced earlier this year that it would carve out its active pharmaceutical ingredient (API) business as a standalone company, creating the world’s second-largest API manufacturer.[1]Its production facilities will include a plant in Ujpest, Hungary. Basel-based Novartis has invested nearly €2bn in Slovenia since 2003, largely through its generics and biosimilars business Sandoz, which has four locations in the country. And in 2019 Sandoz itself announced a deal for the global commercialisation and distribution of a biosimilar to combat multiple sclerosis, to be developed and manufactured by Gdansk-based Polphama Biologics.[2] An export edge Generics manufacturing in particular relies on three factors: low costs, reliable supply chains, and a skilled workforce – including a regulatory team able to spot products coming off patent. CEE has all these factors, making it a prime manufacturing location for the rest of Europe and beyond. -
PRESS RELEASE Goetzpartners Advised Penta Exclusively in the Acquisition of Lloyds Pharmacies and a Pharmaceutical Distributor in the Czech Republic
PRESS RELEASE goetzpartners advised Penta exclusively in the acquisition of Lloyds pharmacies and a pharmaceutical distributor in the Czech Republic Penta Investments, the Central European investment group, has agreed with Celesio AG to acquire its Lloyds pharmacy chain and Gehe wholesale distributor. The purchase price reached EUR 84.5 million. Lloyds operates 55 pharmacies and is the third largest pharmacy chain in the Czech Republic, while Gehe is the fourth biggest wholesale pharmaceutical distributor in the Czech Republic. The transaction is subject to the Czech antitrust authority clearance. goetzpartners acted as exclusive financial advisor to Penta in this transaction. The Lloyds pharmacies will be integrated into Ceska lekarna, a.s, which operates the Dr. Max pharmacy chain on the Czech market. "We are consolidating pharmacies in Central Europe through Dr. Max and its local platforms. The Lloyds pharmacies and an important distributor Gehe have therefore been a very reasonable target for us. We strongly believe that market consolidation in the pharmacy sector significantly contributes to better quality and accessibility of services for patients," said Václav Jirků, Investment Director at Penta. "The integration of Lloyds pharmacies will support our efforts to become the most accessible pharmacy chain in terms of price and location, while the Gehe acquisition is an opportunity to implement our successful Dr. Max business model to the wholesale market. We plan to attract Gehe's independent clients with strategies similar to those we used in the retail market, namely competitive price and services," said Pavel Vajskebr, Dr. Max's CEO. “By this acquisition Penta significantly contributes to strategically improve pharmaceutical distribution in Central Europe, said Dr. -
D6-2 Slovakia
EU Grant Agreement number: 290529 Project acronym: ANTICORRP Project title: Anti-Corruption Policies Revisited Work Package: WP 6 Media and corruption Title of deliverable: D 6.2 Case studies on corruption involving journalists Case studies on corruption involving journalists: Slovakia Due date of deliverable: 31 August, 2016 Actual submission date: 31 August, 2016 Author: Andrej Školkay (SKAMBA) Contributors: Alena Ištoková, Ľubica Adamcová, Dagmar Kusá, Juraj Filin, Martin Matis, Veronika Džatková, Ivan Kuhn, Gabriela Mezeiová and Silvia Augustínová Organization name of lead beneficiary for this deliverable: UNIPG, UNIVERSITÀ DEGLI STUDI DI PERUGIA Project co-funded by the European Commission within the Seventh Framework Programme Dissemination level PU Public X PP Restricted to other programme participants (including the Commission Services) RE Restricted to a group specified by the consortium (including the Commission Services) Co Confidential, only for members of the consortium (including the Commission Services) This project has been supported also by the Slovak Research and Development Agency DO7RP-0039-11 The information and views set out in this publication are those of the author(s) only and do not reflect any collective opinion of the ANTICORRP consortium, nor do they reflect the official opinion of the European Commission. Neither the European Commission nor any person acting on behalf of the European Commission is responsible for the use which might be made of the following information. 1 CONTENTS 1. Introduction p. 3 2. Case study 1: Can a “Lone Wolf” quasi-investigative journalist substitute p. 9 low functionality of the law enforcing system? 3. Case study 2: “Dangerous liaisons” between politicians and journalists in the context p. -
Region Snapshot
CEE/CISAn Overview of Trends in Select Sectors and Markets July 2008 overage of the Central and Eastern Europe (CEE) and Commonwealth of Indepen- Region Snapshot dent States (CIS) markets often mistakenly conveys homogeneity—a monolithic Central and Eastern Europe (CEE) C“emerging Europe.” This brief covers a range of markets under the rubric of CEE includes: and CIS, however with the acknowledgement that these “regions” remain fragmented, Latvia with a core of large, more mature markets coupled with several smaller developing PE Lithuania markets. Estonia Czech Republic Among the CEE markets, more nuanced treatment in the wake of the first wave of Acces- Hungary sion reflects the reality that “CEE” subsumes several discrete investment environments. Poland Slovakia Poland—with 40% of GDP and population among the Accession countries—has captured Romania the majority of private equity investment to date. However, private equity investors are Bulgaria increasingly finding opportunities in markets throughout the region, with the Baltic coun- Albania Slovenia tries and Southeastern Europe emerging as the next frontiers. Croatia The inclusion of Russia among the BRICs obscures the distincitviness of the Russian pri- Bosnia and Herzegovina Serbia vate equity market, over a decade in the making. While Russia continues to draw the bulk Montenegro of investment within the CIS markets, remarkable economic growth in the markets of Republic of Macedonia Ukraine and Kazakhstan is encouraging investors to broaden their scope within the CIS. Turkey Perceptions about investment risk in CEE and CIS markets have improved. But the no- The Commonwwealth of Independent States (CIS) includes: tion that Accession in the CEE markets translates to uniform harmonization with EU stan- dards is misplaced. -
Annual Report
annual report ANNUAL REPORT 2009 AERO VODOCHODY A.S. contents 06 14 20 28 04 FOREWORD OF THE PRESIDENT 22REPORT ON BUSINESS ACTIVITIES General Financial Situation 08 COMPANY PROFILE Revenues Corporate Profile Profit Aerostructures Division Property Structure Defence & MRO Division Financing Resources Portfolio of Companies Human Resources Strategic Objective Environment 36 46 70 10 HISTORY 30 OPINION OF THE SUPERVISORY BOARD Early Days Expansion 32 AUDITOR’S REPORT ON ANNUAL REPORT War Production Prelude to the Future 34 AUDITOR’S REPORT Jet Era ON FINANCIAL STATEMENTS Indigenous Jet Trainers Civil Program 38 FINANCIAL STATEMENTS 12 AERO IN DATA 48 NOTES TO FINANCIAL STATEMENTS 16 KEY EVENTS OF 2009 68 REPORT ON RELATED PARTIES 18 COMPANY BODIES AND MANAGEMENT Organization Chart ANNUAL REPORT 2009 AERO VODOCHODY A.S. foreword of the president 04 05 of the company In 2009, Aero faced adverse situations affected also the employees by reducing their number by 10 %. Thanks in the aerospace market. Virtually all areas to successful start-up of activities in the field of "lean management" of civil aviation program have been affected it was possible to maintain profitability at a decent level and also by significant reductions in demand, but Aero to lay the foundation of long-term maintenance of competitiveness. has succeeded to respond to this negative swing accordingly. Relatively significant cost In 2009, Aero also started its way of "risk-sharing" programs by entering reductions were done, which unfortunately into a contract in June and starting with the project for development and subsequent production of the CSeries aircraft leading edge for the Canadian company Bombardier. -
Central Europe Private Equity Confidence Survey
Rebounding confidence drives mid-market Central Europe Private Equity confidence survey Private Equity May 2016 The confidence to put money to work shows an appetite and willingness to build CE businesses and create returns for investors. This publication contains general information only. The publication has been prepared on the basis of information and forecasts in the public domain. None of the information on which the publication is based has been independently verified by Deloitte and none of Deloitte Touche Tohmatsu Limited, any of its member firms or any of the foregoing’s affiliates (collectively the “Deloitte Network”) take any responsibility for the content thereof. No entity in the Deloitte Network nor any of their affiliates nor their respective members, directors, employees and agents accept any liability with respect to the accuracy or completeness, or in relation to the use by any recipient, of the information, projections or opinions contained in the publication and no entity in Deloitte Network shall be responsible for any loss whatsoever sustained by any person who relies thereon. 2 Introduction Our 27th survey reveals renewed confidence after a dip The EBRD released its latest Transition Report last last autumn. The Index rose by a third to reach 124, autumn1, and reminded us that despite its ability to putting sentiment of Central European (CE) private select high-potential businesses and then help to equity (PE) deal-doers at roughly the level seen a year accelerate their growth, the asset class remains ago. underrepresented in transition countries. In fact the report states that just 1% of global private equity is It is also encouraging to see that confidence is channelled into EBRD countries. -
Investment Market 88 Investment Market
INVESTMENT MARKET 88 INVESTMENT MARKET Poland and the Czech Republic retain the position as the most attractive investment markets in Central and Eastern Europe. Hungary is the mover of the year, with more than twice the volume of investments compared to 2015–2016. The volume of investments in the Czech Republic reached circa 3.6 billion EUR, which is a 30% increase compared to 2015. In 2017 we expect an investment volume in the range of 3–3.5 billion EUR. The reference yield (prime yield) in 2016 decreased in all the monitored sectors: under 5% in the case of top offices (-0.80 percentage points), to 5% in the case of shopping centers (-0.40 percentage points), to the threshold of 3.75% for real estate on shopping strees (-0.75 percentage points), and 6% in the case of warehouses (-0.75 percentage points). INVESTMENT MARKET IN CENTRAL EUROPE In addition to the Czech Republic, record investment The volume of investments in CEE (in Poland, the results were also achieved in Slovakia, with a total volume Czech Republic, Hungary, Slovakia and Romania) of 850 million EUR. The most significant transaction in exceeded 11.7 billion EUR in 2016, which represents Slovakia was the acquisition of the Centrál shopping centre an approximate year-on-year growth of 35%. One of the in Bratislava by Allianz Real Estate (179 million EUR). biggest transactions that closed in 2016 was the GIC’s Additionally, due to the sale of the regional shopping cen- acquisition of the pan-European P3 platform of devel- tres of OC Laugaricio, Korzo Prievidza, Aupark Piešťany opment company P3 by the Singapore state fund GIC and the acquisition of the portfolio of retail parks by Immofi- Real Estate. -
Position Statement Regarding the Public Offer
FORTUNA ENTERTAINMENT GROUP N.V. POSITION STATEMENT Regarding the public offer in cash on all outstanding shares in the capital of Fortuna Entertainment Group N.V. by its majority shareholder Fortbet Holdings Limited, dated 31 March 2017 In accordance with article 18 and Annex G of the Dutch Decree on public offers (Besluit Openbare Biedingen Wft) For the annual general meeting of Fortuna Entertainment Group N.V. to be held on 12 June 2017 at 11.00 hours CET at Amsterdam, the Netherlands 2 June 2017 IMPORTANT INFORMATION This position statement (the Position Statement) does not constitute or form part of an offer to sell, or a solicitation of an offer to purchase or subscribe for, any securities to any person in any jurisdiction. This Position Statement has been published by the management board (the Management Board) and the independent members of supervisory board (the Supervisory Board) (the Supervisory Board and the Management Board are collectively referred to as the FEG Boards) of Fortuna Entertainment Group N.V. (FEG) for the sole purpose of providing information to its shareholders on the Polish Tender Offer and the Czech Voluntary Buy-out Offer (collectively: the Offer) made by Fortbet Holdings Limited (the Offeror), an indirect wholly owned subsidiary of Penta Investments Limited (Penta), to the holders of issued and outstanding ordinary registered shares with a nominal value of EUR 0.01 each in the capital of FEG (the Shares and each a Share; holders of such Shares being referred to as the Shareholders) to purchase for cash their Shares on the terms and conditions as set out in the Offer Memoranda, as required pursuant to section 18 paragraph 2 and Annex G of the Dutch Decree on public offers (Besluit openbare biedingen Wft).